|
1
|
Stability of curcumin in buffer solutions and characterization of its degradation products.
|
J Pharm Biomed Anal
|
1997
|
2.77
|
|
2
|
Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice.
|
Hum Mol Genet
|
1999
|
1.86
|
|
3
|
Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway.
|
J Biol Chem
|
2000
|
1.40
|
|
4
|
Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis.
|
Carcinogenesis
|
2000
|
1.34
|
|
5
|
Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis.
|
Blood
|
1991
|
1.32
|
|
6
|
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer.
|
Br J Cancer
|
2004
|
1.27
|
|
7
|
High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.
|
Br J Cancer
|
1997
|
1.24
|
|
8
|
Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age.
|
Br J Surg
|
2003
|
1.19
|
|
9
|
Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin.
|
J Neurosci
|
1999
|
1.13
|
|
10
|
Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma.
|
Br J Haematol
|
1994
|
1.11
|
|
11
|
Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
|
J Clin Oncol
|
2001
|
1.10
|
|
12
|
Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.
|
Leuk Lymphoma
|
1995
|
1.10
|
|
13
|
Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival.
|
Oncology
|
1999
|
1.09
|
|
14
|
Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
|
Anticancer Res
|
2000
|
1.08
|
|
15
|
Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers. An effective and low-toxic regimen for patients with poor general condition.
|
Oncology
|
1997
|
1.07
|
|
16
|
High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy.
|
Cancer
|
1998
|
1.06
|
|
17
|
Cutaneous manifestations of postthymic T cell malignancies: description of five clinicopathologic subtypes.
|
J Am Acad Dermatol
|
1990
|
1.04
|
|
18
|
Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats.
|
Food Chem Toxicol
|
2000
|
0.99
|
|
19
|
Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation.
|
J Gastroenterol Hepatol
|
1997
|
0.97
|
|
20
|
Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach.
|
Am J Hematol
|
2000
|
0.97
|
|
21
|
Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis.
|
Hum Mol Genet
|
2000
|
0.96
|
|
22
|
Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients.
|
Cancer Chemother Pharmacol
|
2015
|
0.96
|
|
23
|
Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19)--possible clinical significance in advanced gastric cancer.
|
Anticancer Res
|
1998
|
0.96
|
|
24
|
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era.
|
Breast Cancer Res Treat
|
2011
|
0.93
|
|
25
|
Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma.
|
Am J Hematol
|
1999
|
0.93
|
|
26
|
A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
|
Anticancer Res
|
1998
|
0.92
|
|
27
|
Menadione-induced DNA damage in a human tumor cell line.
|
Biochem Pharmacol
|
1991
|
0.91
|
|
28
|
Gastric cancer associated with acute disseminated intravascular coagulation: successful initial treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin.
|
Br J Haematol
|
1998
|
0.91
|
|
29
|
Menadione: spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines.
|
Biochem Pharmacol
|
1991
|
0.91
|
|
30
|
Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.
|
Blood
|
1996
|
0.89
|
|
31
|
Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis.
|
Cancer
|
1993
|
0.89
|
|
32
|
Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil.
|
Br J Cancer
|
2000
|
0.89
|
|
33
|
Acute confusion induced by a high-dose infusion of 5-fluorouracil and folinic acid.
|
J Formos Med Assoc
|
1994
|
0.87
|
|
34
|
Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functions.
|
Exp Hematol
|
2000
|
0.87
|
|
35
|
Angioimmunoblastic lymphadenopathy with dysproteinemia--lack of a prognostic value of clear cell morphology.
|
Oncology
|
1997
|
0.86
|
|
36
|
Characterization of the spectrum of postthymic T-cell malignancies in Taiwan. A clinicopathologic study of HTLV-1-positive and HTLV-1-negative cases.
|
Cancer
|
1988
|
0.86
|
|
37
|
Single-step direct cloning of PCR products.
|
Trends Genet
|
1995
|
0.86
|
|
38
|
Clinicopathologic characteristics of Helicobacter pyloric seropositive gastric adenocarcinomas.
|
J Clin Gastroenterol
|
1995
|
0.86
|
|
39
|
An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin.
|
J Clin Oncol
|
1994
|
0.86
|
|
40
|
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer.
|
Br J Cancer
|
2006
|
0.85
|
|
41
|
Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease.
|
Gut
|
1999
|
0.84
|
|
42
|
Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid.
|
Cancer
|
1996
|
0.84
|
|
43
|
Minimal toxicity to myeloid progenitor cells of weekly 24-hr infusion of high-dose 5-fluorouracil: direct evidence from colony forming unit-granulocyte and monocyte (CFU-GM) clonogenic assay.
|
Pharmacol Toxicol
|
2000
|
0.82
|
|
44
|
Transactivation of the human MDR1 gene by hepatitis B virus X gene product.
|
J Hepatol
|
1998
|
0.82
|
|
45
|
Infrequent hMSH2 mutations in sporadic gastric adenocarcinoma with microsatellite instability.
|
Cancer Lett
|
1997
|
0.81
|
|
46
|
Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
|
Br J Urol
|
1996
|
0.80
|
|
47
|
Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapy.
|
Hepatogastroenterology
|
1999
|
0.80
|
|
48
|
Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma.
|
J Am Acad Dermatol
|
1993
|
0.80
|
|
49
|
Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotypes.
|
Br J Haematol
|
1993
|
0.80
|
|
50
|
Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response.
|
J Urol
|
1996
|
0.80
|
|
51
|
Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
|
Anticancer Res
|
2000
|
0.80
|
|
52
|
Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism.
|
Cancer Res
|
1991
|
0.79
|
|
53
|
The significance of body weight change in non-Hodgkins lymphoma.
|
Anticancer Res
|
2000
|
0.79
|
|
54
|
Keratinocyte growth factor down-regulates expression of the sucrase-isomaltase gene in Caco-2 intestinal epithelial cells.
|
J Biol Chem
|
1998
|
0.79
|
|
55
|
High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma.
|
Cancer
|
1999
|
0.79
|
|
56
|
Tamoxifen enhances the chemosensitivity of bladder carcinoma cells.
|
J Urol
|
1995
|
0.79
|
|
57
|
Bone marrow involvement in non-Hodgkin's lymphoma.
|
Taiwan Yi Xue Hui Za Zhi
|
1989
|
0.79
|
|
58
|
Primary T cell leptomeningeal lymphoma--successful treatment with systemic chemotherapy.
|
Oncology
|
1995
|
0.79
|
|
59
|
Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
|
Oncogene
|
1998
|
0.78
|
|
60
|
Thymic carcinoma with autoimmune syndrome: successful treatment with weekly infusional high-dose 5-fluorouracil and leucovorin.
|
Anticancer Res
|
1997
|
0.78
|
|
61
|
Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer.
|
Br J Cancer
|
2002
|
0.78
|
|
62
|
Comparison of MALT and non-MALT primary large cell lymphoma of the stomach: does histologic evidence of MALT affect chemotherapy response?
|
Cancer
|
2001
|
0.78
|
|
63
|
Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin.
|
Biochem Biophys Res Commun
|
2001
|
0.78
|
|
64
|
Adult non-Hodgkin's lymphoma in Taiwan area: a clinicopathologic study of 123 cases based on working formulation classification.
|
Taiwan Yi Xue Hui Za Zhi
|
1989
|
0.77
|
|
65
|
Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suramin.
|
Clin Cancer Res
|
1998
|
0.77
|
|
66
|
Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virus.
|
J Am Acad Dermatol
|
1992
|
0.77
|
|
67
|
Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers.
|
J Clin Gastroenterol
|
1998
|
0.77
|
|
68
|
Transforming growth factor beta1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells.
|
Biochem J
|
1997
|
0.77
|
|
69
|
Tax of the human T-lymphotropic virus type I transactivates promoter of the MDR-1 gene.
|
Biochem Biophys Res Commun
|
1997
|
0.76
|
|
70
|
Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
|
Anticancer Res
|
2001
|
0.76
|
|
71
|
13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma.
|
Cancer
|
1991
|
0.76
|
|
72
|
Polyprenoic acid in hepatocellular carcinoma.
|
N Engl J Med
|
1996
|
0.75
|
|
73
|
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Br J Cancer
|
2005
|
0.75
|
|
74
|
Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: a pilot study.
|
J Formos Med Assoc
|
1994
|
0.75
|
|
75
|
High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung.
|
Anticancer Res
|
1997
|
0.75
|
|
76
|
Weekly CAF chemotherapy for advanced breast cancer patients.
|
Oncology
|
1997
|
0.75
|
|
77
|
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers.
|
Breast Cancer Res Treat
|
1998
|
0.75
|
|
78
|
A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer.
|
Anticancer Res
|
2001
|
0.75
|
|
79
|
Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
|
Anticancer Res
|
2000
|
0.75
|
|
80
|
Present status of cancer treatment in Taiwan.
|
Gan To Kagaku Ryoho
|
1992
|
0.75
|
|
81
|
Adult acute lymphoblastic leukemia--lineage specific classification of 30 cases.
|
Taiwan Yi Xue Hui Za Zhi
|
1986
|
0.75
|
|
82
|
Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue: clinicopathologic analysis of 19 cases.
|
J Formos Med Assoc
|
1996
|
0.75
|
|
83
|
Megestrol acetate antagonizes cisplatin cytotoxicity.
|
Anticancer Drugs
|
1998
|
0.75
|
|
84
|
Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas.
|
Anticancer Res
|
1997
|
0.75
|
|
85
|
MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer.
|
J Formos Med Assoc
|
1997
|
0.75
|
|
86
|
Expression of growth-related genes and drug-resistance genes in HTLV-I-positive and HTLV-I-negative post-thymic T-cell malignancies.
|
Ann Oncol
|
1991
|
0.75
|
|
87
|
[Allogeneic bone marrow transplantation in the treatment of leukemia--a preliminary report].
|
Taiwan Yi Xue Hui Za Zhi
|
1987
|
0.75
|